Aaron I. Davis, Director at iTeos Therapeutics, Inc. (ITOS), sold 375,000 shares at $27.01 ($10.2M) on 2022-04-29, disclosed to the SEC on 2022-05-02.
Open-market sale of $10.2M ITOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.40 | 150,000 | $4.1M | 40.1% |
| 2 | $27.01 | 115,000 | $3.1M | 30.3% |
| 3 | $28.22 | 10,000 | $282K | 2.8% |
| 4 | $26.91 | 7,300 | $196K | 1.9% |
| 5 | $27.53 | 92,700 | $2.6M | 24.9% |
| Total | $27.32 avg | 375,000 |
| $10.2M |
| 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |